NEIL STAHL Insider Trading $REGN REGENERON PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for NEIL STAHL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NEIL STAHL. NEIL STAHL is SVP Res & Dev Sciences in REGENERON PHARMACEUTICALS INC ($REGN) and SVP Res and Dev Sciences in REGENERON PHARMACEUTICALS INC ($REGN) and SVP Res and Devel Sciences in REGENERON PHARMACEUTICALS INC ($REGN) and SVP Research and Development S in REGENERON PHARMACEUTICALS INC ($REGN) and SVP, PreclinDevel & Biomol Sci in REGENERON PHARMACEUTICALS INC ($REGN) and SVP, Research & Devel Sciences in REGENERON PHARMACEUTICALS INC ($REGN) and SVP, Therap & Clin Prog Dev in REGENERON PHARMACEUTICALS INC ($REGN).
NEIL STAHL in REGENERON PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NEIL STAHL: SVP Res and Devel Sciences, SVP Res & Dev Sciences, SVP Research and Development S, SVP Res and Dev Sciences, SVP, Research & Devel Sciences, SVP, Therap & Clin Prog Dev, SVP, PreclinDevel & Biomol Sci
Holdings: 6,541 shares
Current Value: $2,339,650
Latest Transaction: Dec 18 2014
$REGN Market Capitalization: $37.03B
$REGN Previous Close: $357.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of NEIL STAHL in REGENERON PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | A | 399.66 | 80,750 | 32,272,545 | 80,750 | |
| Dec 18 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | A | 52.03 | 75,000 | 3,902,250 | 123,079 | |
| Dec 18 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 30.63 | 3,264 | 99,976 | 0 | |
| Dec 18 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 30.63 | 3,264 | 99,976 | 6,541 | 3.3 K to 6.5 K (+99.60 %) |
| Nov 24 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 410.10 | 413 | 169,371 | 3,277 | 3.7 K to 3.3 K (-11.19 %) |
| Nov 24 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 409.71 | 1,787 | 732,152 | 3,690 | 5.5 K to 3.7 K (-32.63 %) |
| Nov 24 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 415.16 | 3,107 | 1,289,902 | 5,477 | 8.6 K to 5.5 K (-36.20 %) |
| Nov 20 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 115.29 | 16,757 | 1,931,915 | 0 | |
| Nov 20 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Gift | G | 0.00 | 250 | 0 | 18,584 | 18.8 K to 18.6 K (-1.33 %) |
| Nov 20 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 406.93 | 6,703 | 2,727,652 | 18,834 | 25.5 K to 18.8 K (-26.25 %) |
| Nov 20 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 406.93 | 4,747 | 1,931,697 | 25,537 | 30.3 K to 25.5 K (-15.67 %) |
| Nov 20 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 115.29 | 16,757 | 1,931,915 | 30,284 | 13.5 K to 30.3 K (+123.88 %) |
| Aug 11 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 341.27 | 200 | 68,254 | 13,527 | 13.7 K to 13.5 K (-1.46 %) |
| Aug 11 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 340.04 | 9,829 | 3,342,253 | 13,727 | 23.6 K to 13.7 K (-41.73 %) |
| Aug 11 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 339.33 | 1,617 | 548,697 | 23,556 | 25.2 K to 23.6 K (-6.42 %) |
| Aug 08 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 21.25 | 35,000 | 743,750 | 45,295 | |
| Aug 08 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 341.00 | 200 | 68,200 | 25,173 | 25.4 K to 25.2 K (-0.79 %) |
| Aug 08 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 340.60 | 1,900 | 647,140 | 25,373 | 27.3 K to 25.4 K (-6.97 %) |
| Aug 08 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 341.03 | 117 | 39,901 | 27,273 | 27.4 K to 27.3 K (-0.43 %) |
| Aug 08 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 340.39 | 624 | 212,403 | 27,390 | 28 K to 27.4 K (-2.23 %) |
| Aug 08 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 336.11 | 18,301 | 6,151,149 | 28,014 | 46.3 K to 28 K (-39.51 %) |
| Aug 08 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 336.11 | 2,212 | 743,475 | 46,315 | 48.5 K to 46.3 K (-4.56 %) |
| Aug 08 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 21.25 | 35,000 | 743,750 | 48,527 | 13.5 K to 48.5 K (+258.74 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 21.25 | 40,000 | 850,000 | 80,295 | |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 16.80 | 6,548 | 110,006 | 0 | |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 16.80 | 8,000 | 134,400 | 6,548 | |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 321.17 | 1,640 | 526,719 | 24,391 | 26 K to 24.4 K (-6.30 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 320.60 | 3,575 | 1,146,145 | 26,031 | 29.6 K to 26 K (-12.08 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 319.47 | 3,819 | 1,220,056 | 29,606 | 33.4 K to 29.6 K (-11.43 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 318.51 | 6,418 | 2,044,197 | 33,425 | 39.8 K to 33.4 K (-16.11 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 317.58 | 5,360 | 1,702,229 | 39,843 | 45.2 K to 39.8 K (-11.86 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 316.55 | 1,800 | 569,790 | 45,203 | 47 K to 45.2 K (-3.83 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 324.44 | 3,465 | 1,124,185 | 47,003 | 50.5 K to 47 K (-6.87 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 324.44 | 339 | 109,985 | 50,468 | 50.8 K to 50.5 K (-0.67 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 16.80 | 6,548 | 110,006 | 50,807 | 44.3 K to 50.8 K (+14.79 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 324.44 | 4,234 | 1,373,679 | 44,259 | 48.5 K to 44.3 K (-8.73 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 324.44 | 414 | 134,318 | 48,493 | 48.9 K to 48.5 K (-0.85 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 16.80 | 8,000 | 134,400 | 48,907 | 40.9 K to 48.9 K (+19.56 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 324.44 | 20,865 | 6,769,441 | 40,907 | 61.8 K to 40.9 K (-33.78 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 324.44 | 2,619 | 849,708 | 61,772 | 64.4 K to 61.8 K (-4.07 %) |
| Feb 13 2014 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 21.25 | 40,000 | 850,000 | 64,391 | 24.4 K to 64.4 K (+163.99 %) |
| Dec 19 2013 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 21.25 | 4,705 | 99,981 | 0 | |
| Dec 19 2013 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 21.25 | 4,705 | 99,981 | 24,391 | 19.7 K to 24.4 K (+23.90 %) |
| Dec 17 2013 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | A | 270.43 | 95,000 | 25,690,850 | 95,000 | |
| Dec 17 2013 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | A | 30.63 | 75,000 | 2,297,250 | 121,736 | |
| Dec 17 2013 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 272.73 | 9,302 | 2,536,934 | 19,686 | 29 K to 19.7 K (-32.09 %) |
| May 14 2013 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | A | 268.40 | 4,527 | 1,215,047 | 4,527 | |
| May 14 2013 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 21.92 | 55,438 | 1,215,201 | 0 | |
| May 14 2013 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 277.12 | 9,660 | 2,676,979 | 48,988 | 58.6 K to 49 K (-16.47 %) |
| May 14 2013 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 276.71 | 13,378 | 3,701,826 | 58,648 | 72 K to 58.6 K (-18.57 %) |
| May 14 2013 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 268.40 | 27,873 | 7,481,113 | 72,026 | 99.9 K to 72 K (-27.90 %) |
| May 14 2013 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 268.40 | 4,527 | 1,215,047 | 99,899 | 104.4 K to 99.9 K (-4.34 %) |
| May 14 2013 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 21.92 | 55,438 | 1,215,201 | 104,426 | 49 K to 104.4 K (+113.17 %) |
| Dec 18 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Option Exercise | A | 179.13 | 112,500 | 20,152,125 | 112,500 | |
| Dec 18 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Option Exercise | A | 21.25 | 75,000 | 1,593,750 | 120,295 | |
| Dec 18 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Option Exercise | M | 16.80 | 5,952 | 99,994 | 0 | |
| Dec 18 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Buy | M | 16.80 | 5,952 | 99,994 | 48,988 | 43 K to 49 K (+13.83 %) |
| Dec 18 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Payment of Exercise | F | 179.13 | 8,386 | 1,502,184 | 43,036 | 51.4 K to 43 K (-16.31 %) |
| Dec 03 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Option Exercise | M | 21.92 | 4,562 | 99,999 | 0 | |
| Dec 03 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Option Exercise | M | 20.32 | 4,921 | 99,995 | 0 | |
| Dec 03 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Buy | M | 20.32 | 4,921 | 99,995 | 51,422 | 46.5 K to 51.4 K (+10.58 %) |
| Dec 03 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Buy | M | 21.92 | 4,562 | 99,999 | 46,501 | 41.9 K to 46.5 K (+10.88 %) |
| Dec 03 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Sell | S | 181.01 | 17,182 | 3,110,114 | 41,939 | 59.1 K to 41.9 K (-29.06 %) |
| Nov 21 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Option Exercise | M | 16.80 | 37,500 | 630,000 | 14,548 | |
| Nov 21 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Option Exercise | M | 16.80 | 17,000 | 285,600 | 52,048 | |
| Nov 21 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Sell | S | 175.49 | 2,000 | 350,980 | 59,121 | 61.1 K to 59.1 K (-3.27 %) |
| Nov 21 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Sell | S | 174.47 | 13,157 | 2,295,502 | 61,121 | 74.3 K to 61.1 K (-17.71 %) |
| Nov 21 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Sell | S | 173.80 | 9,200 | 1,598,960 | 74,278 | 83.5 K to 74.3 K (-11.02 %) |
| Nov 21 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Payment of Exercise | F | 167.17 | 16,973 | 2,837,376 | 83,478 | 100.5 K to 83.5 K (-16.90 %) |
| Nov 21 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Payment of Exercise | F | 167.17 | 3,768 | 629,897 | 100,451 | 104.2 K to 100.5 K (-3.62 %) |
| Nov 21 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Buy | M | 16.80 | 37,500 | 630,000 | 104,219 | 66.7 K to 104.2 K (+56.21 %) |
| Nov 21 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Payment of Exercise | F | 167.17 | 7,694 | 1,286,206 | 66,719 | 74.4 K to 66.7 K (-10.34 %) |
| Nov 21 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Payment of Exercise | F | 167.17 | 1,708 | 285,526 | 74,413 | 76.1 K to 74.4 K (-2.24 %) |
| Nov 21 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Devel S ... | Buy | M | 16.80 | 17,000 | 285,600 | 76,121 | 59.1 K to 76.1 K (+28.75 %) |
| Aug 30 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | A | 145.70 | 6,017 | 876,677 | 6,017 | |
| Aug 30 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 21.92 | 40,000 | 876,800 | 55,438 | |
| Aug 30 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 146.41 | 5,998 | 878,167 | 59,121 | 65.1 K to 59.1 K (-9.21 %) |
| Aug 30 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 145.44 | 9,386 | 1,365,100 | 65,119 | 74.5 K to 65.1 K (-12.60 %) |
| Aug 30 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 144.92 | 1,500 | 217,380 | 74,505 | 76 K to 74.5 K (-1.97 %) |
| Aug 30 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 145.70 | 17,099 | 2,491,324 | 76,005 | 93.1 K to 76 K (-18.37 %) |
| Aug 30 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 145.70 | 6,017 | 876,677 | 93,104 | 99.1 K to 93.1 K (-6.07 %) |
| Aug 30 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 21.92 | 40,000 | 876,800 | 99,121 | 59.1 K to 99.1 K (+67.66 %) |
| Jun 20 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res & Dev Scien ... | Option Exercise | A | 115.29 | 16,757 | 1,931,915 | 16,757 | |
| Jun 20 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res & Dev Scien ... | Option Exercise | M | 20.32 | 95,079 | 1,932,005 | 0 | |
| Jun 20 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res & Dev Scien ... | Sell | S | 118.10 | 600 | 70,860 | 59,121 | 59.7 K to 59.1 K (-1.00 %) |
| Jun 20 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res & Dev Scien ... | Sell | S | 117.34 | 4,383 | 514,301 | 59,721 | 64.1 K to 59.7 K (-6.84 %) |
| Jun 20 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res & Dev Scien ... | Sell | S | 116.41 | 9,080 | 1,057,003 | 64,104 | 73.2 K to 64.1 K (-12.41 %) |
| Jun 20 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res & Dev Scien ... | Sell | S | 115.60 | 24,848 | 2,872,429 | 73,184 | 98 K to 73.2 K (-25.35 %) |
| Jun 20 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res & Dev Scien ... | Payment of Exercise | F | 115.29 | 39,411 | 4,543,694 | 98,032 | 137.4 K to 98 K (-28.67 %) |
| Jun 20 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res & Dev Scien ... | Payment of Exercise | F | 115.29 | 16,757 | 1,931,915 | 137,443 | 154.2 K to 137.4 K (-10.87 %) |
| Jun 20 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res & Dev Scien ... | Buy | M | 20.32 | 95,079 | 1,932,005 | 154,200 | 59.1 K to 154.2 K (+160.82 %) |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 16.80 | 50,000 | 840,000 | 69,048 | |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 8.50 | 3,432 | 29,172 | 0 | |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 8.50 | 63,234 | 537,489 | 3,432 | |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 108.09 | 2,025 | 218,882 | 59,121 | 61.1 K to 59.1 K (-3.31 %) |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 107.79 | 19,057 | 2,054,154 | 61,146 | 80.2 K to 61.1 K (-23.76 %) |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 113.47 | 600 | 68,082 | 80,203 | 80.8 K to 80.2 K (-0.74 %) |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 112.10 | 1,115 | 124,992 | 80,803 | 81.9 K to 80.8 K (-1.36 %) |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 111.91 | 600 | 67,146 | 81,918 | 82.5 K to 81.9 K (-0.73 %) |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 110.35 | 17,694 | 1,952,533 | 82,518 | 100.2 K to 82.5 K (-17.66 %) |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 109.61 | 8,510 | 932,781 | 100,212 | 108.7 K to 100.2 K (-7.83 %) |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 108.60 | 2,350 | 255,210 | 108,722 | 111.1 K to 108.7 K (-2.12 %) |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 107.83 | 333 | 35,907 | 111,072 | 111.4 K to 111.1 K (-0.30 %) |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 111.01 | 21,352 | 2,370,286 | 111,405 | 132.8 K to 111.4 K (-16.08 %) |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 111.01 | 7,566 | 839,902 | 132,757 | 140.3 K to 132.8 K (-5.39 %) |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 16.80 | 50,000 | 840,000 | 140,323 | 90.3 K to 140.3 K (+55.36 %) |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 113.35 | 1,597 | 181,020 | 90,323 | 91.9 K to 90.3 K (-1.74 %) |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 113.35 | 257 | 29,131 | 91,920 | 92.2 K to 91.9 K (-0.28 %) |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 8.50 | 3,432 | 29,172 | 92,177 | 88.7 K to 92.2 K (+3.87 %) |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 113.35 | 28,869 | 3,272,301 | 88,745 | 117.6 K to 88.7 K (-24.55 %) |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 113.35 | 4,741 | 537,392 | 117,614 | 122.4 K to 117.6 K (-3.87 %) |
| Feb 15 2012 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 8.50 | 63,234 | 537,489 | 122,355 | 59.1 K to 122.4 K (+106.96 %) |
| Dec 20 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | A | 52.03 | 48,079 | 2,501,550 | 48,079 | |
| Dec 20 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | A | 16.80 | 75,000 | 1,260,000 | 119,048 | |
| Dec 20 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | A | 52.03 | 1,921 | 99,950 | 1,921 | |
| Dec 15 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 51.18 | 8,411 | 430,475 | 59,121 | 67.5 K to 59.1 K (-12.45 %) |
| Nov 15 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 11.64 | 17,182 | 199,998 | 0 | |
| Nov 15 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 11.64 | 17,182 | 199,998 | 67,532 | 50.4 K to 67.5 K (+34.13 %) |
| Sep 08 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Option Exercise | M | 11.64 | 82,818 | 964,002 | 0 | |
| Sep 08 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 70.40 | 16,901 | 1,189,830 | 50,350 | 67.3 K to 50.4 K (-25.13 %) |
| Sep 08 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 69.58 | 8,286 | 576,540 | 67,251 | 75.5 K to 67.3 K (-10.97 %) |
| Sep 08 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 68.77 | 7,373 | 507,041 | 75,537 | 82.9 K to 75.5 K (-8.89 %) |
| Sep 08 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Sell | S | 67.47 | 1,200 | 80,964 | 82,910 | 84.1 K to 82.9 K (-1.43 %) |
| Sep 08 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 65.76 | 34,399 | 2,262,078 | 84,110 | 118.5 K to 84.1 K (-29.03 %) |
| Sep 08 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Payment of Exercise | F | 65.76 | 14,659 | 963,976 | 118,509 | 133.2 K to 118.5 K (-11.01 %) |
| Sep 08 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Research and De ... | Buy | M | 11.64 | 82,818 | 964,002 | 133,168 | 50.4 K to 133.2 K (+164.48 %) |
| Apr 05 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Option Exercise | M | 13.00 | 92,308 | 1,200,004 | 0 | |
| Apr 05 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Sell | S | 46.23 | 22,915 | 1,059,360 | 50,350 | 73.3 K to 50.4 K (-31.28 %) |
| Apr 05 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Sell | S | 45.83 | 11,200 | 513,296 | 73,265 | 84.5 K to 73.3 K (-13.26 %) |
| Apr 05 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Payment of Exercise | F | 45.53 | 31,837 | 1,449,539 | 84,465 | 116.3 K to 84.5 K (-27.37 %) |
| Apr 05 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Payment of Exercise | F | 45.53 | 26,356 | 1,199,989 | 116,302 | 142.7 K to 116.3 K (-18.47 %) |
| Apr 05 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Buy | M | 13.00 | 92,308 | 1,200,004 | 142,658 | 50.4 K to 142.7 K (+183.33 %) |
| Mar 31 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Option Exercise | M | 13.00 | 7,692 | 99,996 | 0 | |
| Mar 31 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Sell | S | 45.00 | 7,692 | 346,140 | 50,350 | 58 K to 50.4 K (-13.25 %) |
| Mar 31 2011 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Buy | M | 13.00 | 7,692 | 99,996 | 58,042 | 50.4 K to 58 K (+15.28 %) |
| Dec 20 2010 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Option Exercise | A | 30.63 | 46,736 | 1,431,524 | 46,736 | |
| Dec 20 2010 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Option Exercise | A | 30.63 | 3,264 | 99,976 | 3,264 | |
| Dec 22 2009 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Option Exercise | A | 21.25 | 45,295 | 962,519 | 45,295 | |
| Dec 22 2009 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Option Exercise | A | 21.25 | 4,705 | 99,981 | 4,705 | |
| Jul 27 2009 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Option Exercise | M | 9.49 | 89,463 | 849,004 | 0 | |
| Jul 27 2009 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Option Exercise | M | 9.49 | 10,537 | 99,996 | 0 | |
| Jul 27 2009 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Sell | S | 21.02 | 2,200 | 46,244 | 350 | 2.6 K to 350 (-86.27 %) |
| Jul 27 2009 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Sell | S | 20.74 | 24,686 | 511,988 | 2,550 | 27.2 K to 2.6 K (-90.64 %) |
| Jul 27 2009 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Payment of Exercise | F | 20.14 | 20,423 | 411,319 | 27,236 | 47.7 K to 27.2 K (-42.85 %) |
| Jul 27 2009 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Payment of Exercise | F | 20.14 | 42,154 | 848,982 | 47,659 | 89.8 K to 47.7 K (-46.94 %) |
| Jul 27 2009 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Buy | M | 9.49 | 89,463 | 849,004 | 89,813 | 350 to 89.8 K (+25,560.86 %) |
| Jul 27 2009 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Sell | S | 20.00 | 10,537 | 210,740 | 350 | 10.9 K to 350 (-96.79 %) |
| Jul 27 2009 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP Res and Dev Sci ... | Buy | M | 9.49 | 10,537 | 99,996 | 10,887 | 350 to 10.9 K (+3,010.57 %) |
| Dec 18 2008 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP, Research & Dev ... | Option Exercise | A | 16.80 | 44,048 | 740,006 | 44,048 | |
| Dec 18 2008 | REGN | REGENERON PHARMACE ... | STAHL NEIL | SVP, Research & Dev ... | Option Exercise | A | 16.80 | 5,952 | 99,994 | 5,952 |